Segmed
PrivateLast Round
Series A
Sep 3, 2024
Total Funding Raised
$17.75M
Momentum Score
25 /100
Company Overview
Segmed is a health technology company that has developed a cloud-based platform to provide access to large-scale, de-identified real-world medical imaging data. Founded in 2019 by a team of Stanford engineers and physicians, the company's mission is to accelerate innovation in healthcare and life sciences by simplifying and speeding up access to diverse, structured, and anonymized medical data. The platform serves researchers, AI developers, and biopharmaceutical companies, enabling them to train and validate AI algorithms, conduct clinical research, and develop new diagnostics and therapeutics. By partnering with a global network of healthcare providers, Segmed aggregates and standardizes data, making it readily available for research and development, which has supported FDA-cleared products.
Sector
AI, Data & Cloud Infrastructure
Verticals
Medical Imaging, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS, Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Segmed Comps
Public and private peers based on sector, stage, and business model.
Segmed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 3, 2024 | ||||
| Seed | Nov 15, 2022 | ||||
| Seed | Dec 2, 2020 | ||||
| Accelerator | Mar 16, 2020 |
Key People
Founding team and executive leadership
Segmed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nina Capital | Seed, Series A, Accelerator |
| Blumberg Capital | Series A, Seed |
| Mighty Capital | Seed |
| Y Combinator | Seed, Series A, Accelerator |
| Alchemist Accelerator | Seed |
| Nova Capital | Series A |
| iGan Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2025
Added Invegasustennahcp, a pharmaceuticals company, as a customer.
- May 13, 2025
David Gascoigne appointed as new Chief Executive Officer.
Segmed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Segmed's valuation, stock price, and market status.
